In today’s complex drug development landscape, PBPK and QSP modeling are key tools that help bridge data, de-risk decisions, and support regulatory interactions.
PBPK Modeling
Physiologically Based Pharmacokinetic (PBPK) models describe drug disposition in the body based on organ-specific physiology and biochemistry. They are commonly used for:
- Predicting human pharmacokinetics from preclinical data
- Inter-species scaling
- Drug-drug interaction (DDI) assessment
- Special population modeling (e.g., pediatric, renal, hepatic)
- Bioequivalence and formulation bridging
- Food effect assessment
PBPK is especially useful in early development and for regulatory submissions, where understanding drug disposition is critical.
QSP Modeling
Quantitative Systems Pharmacology (QSP) models go a step further — integrating drug PK/PD with biological pathways and disease mechanisms. QSP helps answer more complex questions like:
- What is the optimal dose to achieve a desired biological effect?
- Which biomarkers are predictive of response?
- How does disease progression interact with drug action?
- What happens in virtual patient populations?
QSP is often used in translational research, especially for complex indications such as oncology, immunology, or CNS disorders.
PBPK vs. QSP: A Comparison
| Feature | PBPK Modeling | QSP Modeling |
|---|---|---|
| Focus | Drug disposition | Drug–target–disease interaction |
| Scope | Whole-body pharmacokinetics | Systems biology + PK/PD |
| Complexity | Moderate | High |
| Data Requirements | In vitro + physiological | Extensive biological/mechanistic data |
| Use Cases | PK prediction, DDI, special populations | Target validation, dose optimization, simulation |
| Best Stage | Preclinical to early clinical | Discovery to late-stage development |
Conclusion
PBPK and QSP are not competing methods — they are complementary. PBPK helps understand exposure; QSP helps predict response. Used together, they strengthen the foundation of translational and clinical decision-making.
📨 Interested in integrating modeling into your development strategy? Let’s talk.